As of September 2024, Suven Life Sciences has a market cap of $329.47M. This makes Suven Life Sciences the world's 12748th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $224.45M | 30.77% |
2023 | $171.63M | 17.97% |
2022 | $145.49M | -23.18% |
2021 | $189.38M | -1.60% |
2020 | $192.46M | -70.51% |
2019 | $652.73M | 35.56% |
2018 | $481.52M | 11.38% |
2017 | $432.32M | 17.64% |
2016 | $367.49M | -34.94% |
2015 | $564.84M | 26.16% |
2014 | $447.73M | 193.18% |
2013 | $152.71M | 132.52% |
2012 | $65.68M | 161.86% |
2011 | $25.08M | -52.99% |
2010 | $53.35M | -13.30% |
2009 | $61.53M | 79.26% |
2008 | $34.33M | -72.20% |
2007 | $123.49M | 585.55% |
2006 | $18.01M | 71.39% |
2005 | $10.51M | -18.63% |
2004 | $12.92M | -4.55% |
2003 | $13.53M | - |